A biotech company aiming to combat (emerging) viral infectious diseases. We are developing novel antiviral drugs that inhibit proteases and viral replications.
Thrilled to share news of #JLABSBE company @Protinhi's acceptance into #BLUEKNIGHT, a @JLABS & @BARDA initiative! Through #BLUEKNIGHT, we support companies worldwide who are dedicated to the challenges associated w/ priority pathogen families: https://t.co/R44x7zQjFq
Aside from #covid19, the world is facing a #dengue challenge as well, see this very relevant Reuters report. https://t.co/JlWHkkNhmp
Protinhi Therapeutics is developing #antiviral treatments against dengue and corona.
#drugdiscovery#therapeutics
We are proud to be selected as one of the speakers pitching in the event “Indo-Dutch Innovation During Crisis.”
Join us in the event and let’s overcome this global challenge together.
#Antivirals#DrugDiscovery